$60,000 of CARDINAL HEALTH INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. The Preserving Patient Access to Long-Term Care Pharmacies Act (H.R. 5031 / S. 3159)"
You can find more data on corporate lobbying on Quiver Quantitative.
CAH Congressional Stock Trading
Members of Congress have traded $CAH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CAH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CAH Insider Trading Activity
CAH insiders have traded $CAH stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:
- JASON M. HOLLAR (Chief Executive Officer) has made 0 purchases and 5 sales selling 143,606 shares for an estimated $21,424,215.
- AARON E ALT (Chief Financial Officer) has made 0 purchases and 2 sales selling 48,243 shares for an estimated $7,177,389.
- STEPHEN M MASON (CEO, GMPD Segment) has made 0 purchases and 3 sales selling 41,575 shares for an estimated $6,187,063.
- JESSICA L MAYER (Chief Legal/Compliance Officer) has made 0 purchases and 3 sales selling 38,078 shares for an estimated $5,666,832.
- OLA M SNOW (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 28,151 shares for an estimated $4,192,916.
- DEBORAH WEITZMAN (CEO, PSS Segment) sold 21,367 shares for an estimated $3,216,374
- MICHELLE D. GREENE (Chief Information Officer) has made 0 purchases and 2 sales selling 13,500 shares for an estimated $2,009,043.
- MARY C. SCHERER (Chief Accounting Officer) sold 6,766 shares for an estimated $1,009,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CAH Hedge Fund Activity
We have seen 562 institutional investors add shares of CAH stock to their portfolio, and 578 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 3,511,579 shares (+153.2%) to their portfolio in Q3 2025, for an estimated $551,177,439
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,449,400 shares (+94.9%) to their portfolio in Q3 2025, for an estimated $384,457,824
- MARSHALL WACE, LLP removed 1,864,356 shares (-96.6%) from their portfolio in Q3 2025, for an estimated $292,629,317
- HOLOCENE ADVISORS, LP added 1,128,358 shares (+141.4%) to their portfolio in Q3 2025, for an estimated $177,107,071
- BLACKROCK, INC. added 916,791 shares (+3.0%) to their portfolio in Q3 2025, for an estimated $143,899,515
- FMR LLC removed 854,880 shares (-13.6%) from their portfolio in Q3 2025, for an estimated $134,181,964
- TWO SIGMA INVESTMENTS, LP removed 844,727 shares (-84.6%) from their portfolio in Q3 2025, for an estimated $132,588,349
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CAH Analyst Ratings
Wall Street analysts have issued reports on $CAH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 11/04/2025
- TD Cowen issued a "Buy" rating on 11/03/2025
- UBS issued a "Buy" rating on 10/31/2025
- Leerink Partners issued a "Outperform" rating on 08/12/2025
To track analyst ratings and price targets for CAH, check out Quiver Quantitative's $CAH forecast page.
CAH Price Targets
Multiple analysts have issued price targets for $CAH recently. We have seen 9 analysts offer price targets for $CAH in the last 6 months, with a median target of $220.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $237.0 on 01/15/2026
- Daniel Grosslight from Citigroup set a target price of $244.0 on 01/09/2026
- Glen Santangelo from Barclays set a target price of $243.0 on 12/09/2025
- Steven Valiquette from Mizuho set a target price of $210.0 on 11/04/2025
- Charles Rhyee from TD Cowen set a target price of $225.0 on 11/03/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $220.0 on 10/31/2025
- Kevin Caliendo from UBS set a target price of $220.0 on 10/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
